← Back to directory
BC
Brandon Capital
Melbourne, AustraliaWebsite ↗
Brandon Capital is Australasia's leading life sciences venture capital firm, dedicated to creating, funding, and growing new biotech and healthcare companies. They aim to transform promising medical research breakthroughs into medical therapies that improve patients' lives globally.
Last raised
Jul 2025
1y 2mo ago
Latest fund size
$289.7M
Brandon BioCatalyst Fund Six
AUM
$924M
estimated
Funds raised
Capital this firm has raised, newest first
Medical Research Commercialisation Fund
Unknown
—
Brandon BioCatalyst Fund Six
Jul 2025 · BB6
$289.7M
MRCF5
Jan 2017 · Fifth Fund
$138.6M
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| Myricx BioLead | Growth | $1.5B | Jul 2026 | fidelity.com ↗ |
| Lumonus | Seed | — | Mar 2026 | source ↗ |
| OncoRes Medical | — | $17.8M | Feb 2026 | source ↗ |
| ENA Respiratory | Series B | $22.4M | Oct 2025 | source ↗ |
| NRG Therapeutics | Series B | — | Sep 2025 | source ↗ |
| AstronauTx | Series A | $61M | Oct 2023 | source ↗ |
Sources
Where this data came from